- Home
- GOSS vs NWFL Comparison
GOSS vs NWFL Comparison
Compare GOSS & NWFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- NWFL
- Stock Information
- Founded
- GOSS 2015
- NWFL 1870
- Country
- GOSS United States
- NWFL United States
- Employees
- GOSS N/A
- NWFL N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- NWFL Major Banks
- Sector
- GOSS Health Care
- NWFL Finance
- Exchange
- GOSS Nasdaq
- NWFL Nasdaq
- Market Cap
- GOSS 212.9M
- NWFL 246.4M
- IPO Year
- GOSS 2019
- NWFL 1998
- Fundamental
- Price
- GOSS $0.80
- NWFL $26.10
- Analyst Decision
- GOSS Strong Buy
- NWFL
- Analyst Count
- GOSS 5
- NWFL 0
- Target Price
- GOSS $9.20
- NWFL N/A
- AVG Volume (30 Days)
- GOSS 2.3M
- NWFL 15.7K
- Earning Date
- GOSS 11-07-2024
- NWFL 01-27-2025
- Dividend Yield
- GOSS N/A
- NWFL 4.53%
- EPS Growth
- GOSS N/A
- NWFL N/A
- EPS
- GOSS N/A
- NWFL 1.59
- Revenue
- GOSS $105,322,000.00
- NWFL $62,305,000.00
- Revenue This Year
- GOSS N/A
- NWFL N/A
- Revenue Next Year
- GOSS N/A
- NWFL N/A
- P/E Ratio
- GOSS N/A
- NWFL $19.30
- Revenue Growth
- GOSS N/A
- NWFL N/A
- 52 Week Low
- GOSS $0.50
- NWFL $23.50
- 52 Week High
- GOSS $1.60
- NWFL $34.50
- Technical
- Relative Strength Index (RSI)
- GOSS 50.75
- NWFL 27.05
- Support Level
- GOSS $0.83
- NWFL $29.96
- Resistance Level
- GOSS $1.10
- NWFL $30.68
- Average True Range (ATR)
- GOSS 0.08
- NWFL 0.52
- MACD
- GOSS 0.02
- NWFL -0.33
- Stochastic Oscillator
- GOSS 31.66
- NWFL 3.14
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About NWFL Norwood Financial Corp.
Norwood Financial Corp is a U.S.-based bank holding company. It offers various personal and business credit services, trust and investment products, and real estate settlement services to consumers, businesses, nonprofit organizations, and municipalities in each of the communities that the bank serves. The bank also manages automated teller machines at its branch location. It serves the Pennsylvanian counties of Wayne, Pike, Monroe, and Lackawanna, as well as Susquehanna County.